APA (7. basım) Alıntı

Rong, Z., Li, L., Fei, F., Luo, L., & Qu, Y. (2025). Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer. BMC.

Chicago Style (17. basım) Atıf

Rong, Zhe, Li Li, Fei Fei, Lailong Luo, ve Yang Qu. Retraction Note: Combined Treatment of Glibenclamide and CoCl2 Decreases MMP9 Expression and Inhibits Growth in Highly Metastatic Breast Cancer. BMC, 2025.

MLA (9th ed.) Atıf

Rong, Zhe, et al. Retraction Note: Combined Treatment of Glibenclamide and CoCl2 Decreases MMP9 Expression and Inhibits Growth in Highly Metastatic Breast Cancer. BMC, 2025.